🔗 References (max. 100)

show query show view
part subject predicate object published by date
Assertion
Assertion
The on‐label indication for Brintellix is depression; we identified the following off‐label indications: schizophrenia, episodic mood disorders, anxiety disorders, personality disorders, bipolar depression, post‐traumatic stress disorder, and chronic pain.
Assertion
Assertion
Assertion
Assertion
Assertion
Assertion
Assertion
Assertion